Fake meningitis vaccines currently on sale has been detected by the relevant services in Niamey.
Immediately, the Ministry of Public Health carried out customary checks and transmitted its findings to WHO, which then issued an alert to inform people and health workers.
The World Health Organization (WHO) also initiated an investigation before issuing Medical Product Alert No. 1/2017 entitled “Falsified meningococcal vaccine in circulation in West Africa.”This alert refers to the recent circulation in Niger of falsified confirmed versions of meningococcal serotype ACWY vaccine.
A press release from the Ministry of Public Health, “highlighted the truth of the facts, and alerted populations, health professionals and customary and religious authorities not to use this product.
According to the WHO, on the basis of the edifying elements transmitted by the Ministry of Public Health of Niger, on 31 May 2017, the manufacturer “Bio-Manguinhos / Fiocruz” informs the WHO that a falsified version of the product – Polysaccharide Meningococcal ACWY Vaccine from lot 089UMH002 Z – is available in Niger: the date of manufacture is September 2014 while the expiry date indicates September 2017.
Although according to the international organization “at this stage no adverse post-vaccination manifestations attributed to this product are known or notified in the light of the above facts any ACWY meningococcal vaccine claiming to be made by the manufacturer – Bio-Man- Guinhos / Fiocruz, was to be regarded as falsified and notified.”
Hence, the WHO recommendations to health workers who would come into possession of such a product:”Please do not use them, contact a qualified healthcare professional immediately and notify the Ministry of Health /National Drug Regulatory Authority/National Pharmacovigilance Center; Please consult a qualified health professional immediately if you have been immunized with this product, or if you have any undesirable adverse events, and notify the incident as described above; Persons with knowledge of falsified medical products for sale must notify their national health authorities; It is necessary to obtain any medical product from authentic and reliable sources.
WHO recommends increased vigilance in the supply chains of countries potentially affected by these falsified products. This vigilance should include hospitals, clinics, pharmacies and all points of sale and distribution of medical products.
Extracts, TamtamInfo News
Photo Credit: PATH Africa Launch of Meningitis Campaign